A synthetic short peptide bioregulator in the Khavinson tradition, associated with thymic/immune tissue and studied as an immunomodulator. Commonly included in Cytogen combination protocols with Vilon and Thymogen. Sequence identification varies between vendor and literature sources; flagged for independent-source verification.
For research purposes only. Not medical advice.
Ruo Bio currently lists Crystagen at $1.15/mg, the lowest indexed price across 1 tracked research peptide vendor.
1 research peptide vendor currently lists Crystagen on PeptideScouter. We track 1 active listing across size and kit variants.